ANXA5 and cancer: Next, by using immunoblotting (Figure 4A) and Annexin V staining assay (Figure 4B), we examined whether the suppression of DR4 and/or DR4 by siRNA can abrogate the sensitizing effects of CIP on cancer cells to TRAIL-induced apoptosis.